Blank Rome Enhances Life Sciences Team with Former FDA Lawyer

What's Happening?

Blank Rome LLP has announced the addition of Tom Sundlof as a partner in its life sciences industry team and corporate, M&A, and securities practice group in Washington, DC. Sundlof, who previously served in the FDA’s Office of the Chief Counsel, will focus on regulatory, compliance, and enforcement matters related to medical devices, combination products, and other FDA-regulated items. His role will involve assisting both domestic and international clients in navigating FDA regulations, from clinical trial design to post-market compliance.

Why It's Important?

The recruitment of Tom Sundlof by Blank Rome signifies a strategic enhancement of the firm's capabilities in the life sciences sector, particularly in regulatory and compliance matters. This move is crucial as the life sciences industry faces increasing regulatory scrutiny and complex compliance requirements. Sundlof's expertise will be valuable for clients seeking to ensure their products meet FDA standards, thereby reducing the risk of regulatory issues. This development highlights the growing importance of legal expertise in navigating the intricate landscape of FDA regulations, which is vital for the success and innovation of life sciences companies.

What's Next?

With Sundlof's addition, Blank Rome is expected to strengthen its service offerings to clients in the life sciences sector, potentially attracting more business from companies seeking robust legal support in regulatory matters. The firm may also expand its influence in the Washington, DC area, leveraging Sundlof's experience and connections. For clients, this means enhanced guidance in achieving compliance and navigating the regulatory environment, which could lead to smoother product development and market entry processes.